試す 金 - 無料
Indian pharma dodges Trump bullet for now
Mint Mumbai
|September 27, 2025
‘operate US manufacturing or repackaging units and are exploring further acquisitions,” said Namit Joshi, chairman of Pharmexcil (Pharmaceuticals Export Promotion Council of India).
-
India ships mostly generic medicines to the US. MINT
“Nonetheless, it is prudent to remain prepared for future policy shifts and to build risk-mitigation strategies.”
The commerce ministry didn't respond to queries.
Patented drugs are new, unique medicines developed by a company and are often very expensive. Generic drugs are low-cost versions of these medicines produced once the patent expires. The global market for generic drugs is projected to reach about $468.08 billion this year, according to a report by Canadian research firm Precedence Research.
このストーリーは、Mint Mumbai の September 27, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint Mumbai からのその他のストーリー
Mint Mumbai
Tata Trusts strife bares a void
Today's meeting may set the tone for the philanthropic entities' future, a year after the death of Ratan Tata
4 mins
October 10, 2025
Mint Mumbai
Silver ETFs fired up by scarcity, festivals
Silver exchange traded funds or ETFs opened Thursday with a record 10-12% premium to spot prices, underscoring a scramble for the metal as festive buying, industrial use, and investor FOMO (fear of missing out) drove up demand against tight supplies.
2 mins
October 10, 2025
Mint Mumbai
AI BROKE THE INFO BOTTLENECK, BUT VALUE INVESTING STILL DEPENDS ON INSIGHT
In a Bloomberg column, Guy Spier argues that AI has ended the golden age of value investing by removing the old information edge.
2 mins
October 10, 2025
Mint Mumbai
TCS preps big pivot to AI, data centres
At least $6 bn investment in 6 yrs; Q2 revenue beats expectations
3 mins
October 10, 2025
Mint Mumbai
INDUSIND BANK RATED INDIA INVOLVED BY SKOCH FOR EXCELLENCE IN MSME BANKING
Once upon a spreadsheet, India's MSMEs were drowning in paperwork, late payments and queues that snaked through branch corridors like endless fiscal serpents.
2 mins
October 10, 2025
Mint Mumbai
Sunjay Kapur's will forged, ex-wife's children tell court
Dispute revolves around ₹30,000-cr estate contested between Kapur's kids and widow Priya
3 mins
October 10, 2025
Mint Mumbai
India to ease US trade barrier pressure for medical devices
The plan may include subsidies, mutual recognition pacts for easy acceptance of Indian items
2 mins
October 10, 2025
Mint Mumbai
Akasa co-founder Khatri exits after ₹1,200 cr funding
Ex-IAF officer's departure is the first from the founding team since the carrier's 2022 launch.
1 mins
October 10, 2025
Mint Mumbai
HC nod to Natco for generic Risdiplam
In a setback to Swiss pharma major Roche, the Delhi High Court has refused to restrain local drugmaker Natco Pharma from selling a generic version of lifesaving drug Risdiplam in India, upholding a March single-judge order.
1 mins
October 10, 2025
Mint Mumbai
Razorpay to enter four new markets in South-East Asia
Initial public offering (IPO)-bound fintech major Razorpay is planning to expand into three to four new South-East Asian markets by the end of 2026, the firm's top executive told Mint in an interaction.
1 mins
October 10, 2025
Listen
Translate
Change font size